NuclixBio

Business Services · 11-50 Employees

View Company Info for Free

Overview

Revenue

$5.9 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About NuclixBio

NuclixBio, Inc. is a pre-clinical stage biotech company focusing on early-stage research and development of intracellularly targeted nucleic acid therapeutics that are based on proprietary platform technologies. With its own circular mRNA platform ringRNA, NuclixBio has established additional strong therapeutics platform such as Ribo-TaP and Ribo-grAb, and is currently developing targeted oncology and immuno-oncology therapeutics assets.Explore more
NuclixBio's Social MediaPopular SearchesNuclixBio IncNuclixBioSIC Code 87,873NAICS Code 54,541Show more

Is NuclixBio your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

NuclixBio is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

NuclixBio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about NuclixBio.

NuclixBio Tech Stack

A closer look at the technologies used by NuclixBio

NuclixBio News & Media

  • NuclixBio Announces a Collaborative Research Agreement with PharmAbcine

    SEOUL, South Korea, March 14, 2022 /PRNewswire/ -- NuclixBio Inc., a South Korean biotech company that focuses on research and development of mRNA therapeutics, announced today that it has signed a Collaborative Research Agreement with PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics. Under the agreement, both companies will conduct collaborative research utilizing NuclixBio's proprietary circular mRNA plat
Read more news

Top Business Services Companies

Frequently Asked Questions Regarding NuclixBio

What is NuclixBio's official website?
NuclixBio's official website is www.nuclixbio.com
What is NuclixBio's Revenue?
NuclixBio's revenue is $5.9 Million
What is NuclixBio's SIC code?
NuclixBio's SIC: 87,873
What is NuclixBio's NAICS code?
NuclixBio's NAICS: 54,541
How many employees does NuclixBio have?
NuclixBio has 11-50 employees
What industry does NuclixBio belong to?
NuclixBio is in the industry of: Business Services, Research & Development
What technology does NuclixBio use?
Some of the popular technologies that NuclixBio uses are: PHP, YouTube, Cafe24, Google Workspace
What does NuclixBio do?

NuclixBio, Inc. is a pre-clinical stage biotech company focusing on early-stage research and development of intracellularly targeted nucleic acid therapeutics that are based on proprietary platform technologies. With its own circular mRNA platform ringRNA, NuclixBio has established additional strong therapeutics platform such as Ribo-TaP and Ribo-g... rAb, and is currently developing targeted oncology and immuno-oncology therapeutics assets.Read More

What are NuclixBio social media links?
NuclixBio Linkedin page
Is NuclixBio a public company?
NuclixBio is private company therefore does not currently have an official ticker symbol
See more information about NuclixBio

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.